GamaMabs Pharma - AMHR2 Antibody Technology - Ownership and Business Overview

Life ScienceCompany

GamaMabs Pharma - AMHR2 Antibody Technology Ownership

Who owns GamaMabs Pharma - AMHR2 Antibody Technology?

GamaMabs Pharma - AMHR2 Antibody Technology is owned by Exelixis. It was acquired on May 4, 2021.

GamaMabs Pharma - AMHR2 Antibody Technology Business Overview

Where is GamaMabs Pharma - AMHR2 Antibody Technology headquartered?

GamaMabs Pharma - AMHR2 Antibody Technology is headquartered in Toulouse, France.

What sector is GamaMabs Pharma - AMHR2 Antibody Technology in?

GamaMabs Pharma - AMHR2 Antibody Technology is a life science company.

Life Science M&A Summary in 2021

Out of 60 sectors in the Mergr database, life science ranked 7 in number of deals in 2021. The largest life science acquisition in 2021 was Pharmaceutical Product Development - which was acquired by Thermo Fisher Scientific for $17.4B.

Subscribe to Mergr to view all 400 acquisitions of life science companies in 2021, including 47 acquisitions by private equity firms, and 353 by strategics.

Acquired by Exelixis, Inc. (Company) on 2021-05-04

GamaMabs Pharma - AMHR2 Antibody Technology

Toulouse,
France,

GamaMabs Pharma's AMHR2 Antibody Technology provides the development of optimized antibodies targeting AMHR2 for the treatment of cancer.

Company Summary

SECTOR

Investor History
2021-05-04
Divestiture

5M USD

Exelixis

GamaMabs Pharma

Subscribe to unlock this and 215,016
investor and company profiles

Sign-up today to get full access

Unlimited Searches
Unlimited Profile Views
Build and Export Lists of

PE Backed Companies
Direct Investors & Acquirers
Advisors
Deals
& More

Get Full Access

What's Mergr?

Mergr is a user-friendly database designed to simplify the complex world of private equity and M&A for busy professionals.

We created Mergr to eliminate the challenge of tracking company acquisitions, sales, and ownership, providing clear insights into investment firms and their activities. For example, explore a company's M&A activity, ownership history, and connections - organized to help you uncover opportunities and make informed decisions.

With Mergr, gain access to a comprehensive, interconnected web of transactions, investors, companies, and advisors - all in one place.

Mergr, the Easiest-to-Use PE and M&A DB

Key Benefits

Stay informed on events in your industry
M&A research that takes seconds (not all afternoon)
Better understand your customers and prospects
Discover active buyers (or sellers)

Search

4.7K Private Equity Firms
208K M&A Transactions
210K Companies Involved in M&A
(Buyer, Seller, or Target)
3.7K M&A Advisors
(Investment Banks and Law Firms)
81K M&A Contacts
(PE and M&A Advisors)

What next?

Get Full Access

Full access to Mergr's investor, acquirer, and transaction data starts here.

Related Lists for GamaMabs Pharma - AMHR2 Antibody Technology

Life Science Companies

Related Lists for Life Science Companies

Largest Life Science Companies , Acquisitive Life Science Companies , Recently Acquired Life Science Companies , Recently Sold Life Science Companies , Private Life Science Companies , Public Life Science Companies , Acquired Life Science Companies , PE Backed Life Science Companies